Cooper Consumer Health

What Cooper Consumer Health does

Cooper Consumer Health is a Paris-headquartered consumer health company that began in 1907 as a pharmacists' cooperative outside Paris and has grown into Europe's largest independent pure-play self-care platform. It sells OTC medicines, personal care, and wellbeing products through a portfolio of approximately 25 heritage brands — including Betadine, CB12, Etiaxil, Mag2, Saugella, Valdispert, Excilor, Endwarts, and Nicotinell — reaching millions of consumers through pharmacy networks, retail partners, and direct commercial operations across at least eight European countries (France, Italy, Germany, Spain, the Netherlands, Portugal, the UK, and Central and Eastern Europe via MagnaPharm). The company is majority owned by CVC Capital Partners and currently reports €1.1 billion in net sales with a workforce of 1,600+ employees representing more than 30 nationalities.

Name

Cooper Consumer Health

Legal name

Cooper Consumer Health

Website

https://cooperconsumerhealth.eu

Company type

Private

Founded year

1907

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Cooper Consumer Health is Europe's largest independent pure-play self-care platform, selling OTC medicines, personal care, and wellbeing products across 25 heritage brands and generating €1.1 billion in net sales via pan-European pharmacy and retail channels.

Ownership category

akta.pro rank

Product category

Over-the-Counter Consumer Health

NAICS

Health and Personal Care Retailers (456), Food (Health) Supplement Retailers (456191)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Cold, Flu, Cough & Allergy Remedies (Decongestants, Antihistamines, Cough Syrups, Lozenges) (CRADAMAD)

akta.pro secondary industries

Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests) (CRADAMAH), Smoking Cessation & Nicotine Replacement Therapy (Gum, Patches, Lozenges) (CRADAMAI), Probiotics & Digestive Health Supplements (CRADAGAF), Multivitamins & Daily Packs (CRADAGAC)

Keywords

• Over-the-counter medicines
• Consumer health brands
• Personal care products
• Wellbeing supplements
• Pharmacy distribution

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Marketing or Sales, Technology or R&D

Revenue model

1. Consumer Health Product Sales: Revenue generated from the sale of OTC medicines, personal care products, and wellbeing solutions through retail and pharmacy channels across Europe. The company operates a multi-brand portfolio strategy with products ranging from antiseptics and wound care to oral hygiene, women's health, and sweat care.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Cooper Consumer Health manufactures and sells a multi-brand portfolio of over-the-counter medicines, personal care products and wellbeing solutions across more than 15 European countries. Its offering spans three product families — wellbeing solutions, essential health, and personal care — distributed under 25+ heritage brands (including Betadine, CB12, Etiaxil, Excilor, Mag2, Sargenor, Valdispert and Saugella) through pharmacy, drugstore and retail channels.

Product overview

Cooper Consumer Health is Europe's largest independent pure-play selfcare platform offering a diverse portfolio of consumer health products. The company provides solutions across three main categories: Wellbeing Solutions (ongoing health maintenance), Essential Health (short-term health concerns like antiseptics, wound care, cold/flu, digestive health), and Personal Care (oral hygiene, women's health, sweat care). The portfolio includes approximately 25 top brands such as Mag2, Etiaxil, Endwarts, Betadine, CB12, Excilor, Saugella, Sargenor, Armolipid, Valdispert, Froben, Kamillosan, Dagravit, Pouxit, and Agiolax. Following the July 2024 acquisition of Viatris' OTC business, the company expanded to include brands like Nicotinell (smoking cessation). The company operates 5 manufacturing sites, 1 R&D hub, and 10 office sites across Europe, with €1.1B in net sales and over 1,600 employees.

Differentiator

Problem solved

Functional benefit

Brands

• Baccide: Personal care brand
• Dermafresh
• Salviagalen
• Mag2
• Etiaxil
• Endwarts
• Betadine
• CB12
• Excilor
• Saugella
• Sargenor
• Armolipid
• Valdispert
• Froben
• Kamillosan
• Dagravit
• Pouxit
• Agiolax
• Nicotinell

Products and services

• Mag2 Heritage French brand of magnesium-based oral supplements sold across European pharmacy channels to consumers seeking relief from fatigue, stress and magnesium deficiency.
• Etiaxil Heritage brand of antiperspirant products for excessive sweating (hyperhidrosis), sold across European pharmacy and drugstore channels.
• Endwarts Topical treatment for the removal of common warts and verrucas, sold in European pharmacy channels.
• Betadine Heritage iodine-based antiseptic range for wound disinfection, skin and mucosal antisepsis, sold across European pharmacy and consumer health channels.
• CB12 Mouthwash and oral care range targeting bad breath (halitosis), sold across European pharmacy and drugstore channels.
• Excilor Topical treatment range for onychomycosis (nail fungus), sold across European pharmacy and consumer health channels.
• Saugella Intimate hygiene product range (cleansers, washes and care products), sold across European pharmacy and consumer health channels.
• Sargenor Oral supplement range based on arginine and B vitamins for fatigue and energy support, sold across European pharmacy channels.
• Armolipid Nutraceutical product range supporting healthy cholesterol and lipid levels, sold across European pharmacy channels.
• Valdispert Herbal-based oral supplement range supporting stress relief and sleep, sold across European pharmacy channels.
• Froben Flurbiprofen-based OTC range for pain, inflammation and sore throat relief, sold across European pharmacy channels.
• Kamillosan Chamomile-based OTC range for skin, mucosal and respiratory care, sold across European pharmacy channels.
• Dagravit Vitamin and mineral supplement range supporting daily nutritional needs, sold across European pharmacy channels.
• Pouxit Head-lice treatment product range (shampoos, lotions and combs), sold across European pharmacy channels.
• Agiolax Plant-based laxative and digestive regularity range, sold across European pharmacy channels.
• Nicotinell Nicotine replacement therapy (NRT) range (patches, gum, lozenges) for smoking cessation, sold across European pharmacy and consumer health channels.
• Baccide Hand and surface hygiene product range (sanitizers and cleansing products), sold across European pharmacy and consumer health channels.
• Dermafresh Skincare product range for sensitive skin and dermatological cleansing, sold across European pharmacy channels.
• Salviagalen Herbal-based product range for sore throat and oral-mucosal care, sold across European pharmacy channels.

Named customers1 record

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Four partnerships are on record, tiered core.

• Ferrer Consumer HealthcarecoreStrategic or Co-development Partner · 1 June 2026Cooper Consumer Health acquired the Ferrer Consumer Healthcare business in Spain in June 2026. This acquisition represents another step-change for the company, expanding its presence in the Spanish market and adding to its portfolio of consumer health brands.
• NicotinellcoreOthers · 11 December 2025Successful go-live of the Nicotinell portfolio across Europe in December 2025, following the Viatris OTC acquisition. Nicotinell is a smoking cessation brand that became part of Cooper's portfolio.
• MagnaPharmcoreChannel Partner/ Reseller/ Distributor · 1 January 2025Cooper Consumer Health partnered with MagnaPharm for distribution in Central and Eastern Europe. This partnership extends the company's geographic reach into CEE markets, leveraging MagnaPharm's established distribution network for consumer health products.
• ViatriscoreStrategic or Co-development Partner · 3 July 2024Cooper Consumer Health completed the acquisition of Viatris' OTC (Over the Counter) business on July 3, 2024. This was the largest divestiture among Viatris' strategic portfolio simplification efforts, including manufacturing and R&D sites in France and Italy. The transaction significantly expanded Cooper's scale and portfolio.

Scale indicators9 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Church & Dwight: US-listed global consumer health and personal care company (Arm & Hammer, First Response, Batiste); adjacent OTC and personal-care brand model with overlap in oral care, women's health, and personal hygiene.
• Perrigo Company: US-listed global OTC and self-care company with a sizeable European business (Opella divestiture aside), offering store-brand and branded OTC across many of the same categories — smoking cessation, oral care, digestive health, and personal care.
• Bayer Consumer Health: Division of Bayer AG focused on OTC, self-care and wellness products across Europe; overlaps directly with Cooper's categories in pain relief, digestive health and dermatology at meaningful scale.
• Haleon (formerly GSK Consumer Healthcare): London-listed global consumer healthcare giant spanning oral care, pain relief, and wellness; a broad incumbent whose pan-European OTC bench competes with Cooper brands like CB12, Froben and Valdispert on pharmacy shelves.
• Sanofi Consumer Healthcare (Opella): Sanofi-affiliated consumer healthcare business being carved out, covering allergy, cough/cold, and personal care across European retail and pharmacy — directly comparable channel and category mix to Cooper.

Direct peers

• Stada Arzneimittel: German-headquartered, PE-owned (Bain & Cinven/CapVest) pan-European OTC generics and consumer health platform with overlapping categories like cough/cold, dermatology, and women's health; the most direct strategic peer given its parallel PE ownership and reported acquisition interest in Cooper.
• Prestige Consumer Healthcare: US-listed OTC and personal care platform with a roll-up M&A strategy analogous to Cooper's; targets brand-led consumer health niches across North America and Europe with similar business model.
• Omega Pharma: Belgian-headquartered European OTC and personal care specialist (owned by Perrigo); pure-play self-care portfolio with overlapping categories in weight management, intimate care, and dermatology — a small-scale but close analog to Cooper.

Emerging players

• Dexcel Pharma: Israel-based specialty pharma with European OTC and self-care consumer health brands; smaller-scale but competes in similar niches including women's health, dermatology, and OTC remedies.
• Recordati: Italian specialty pharma with growing consumer health presence; competes with Cooper in selected OTC and self-medication categories and shares part of the Italian/European geographic footprint.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/cooper-consumer-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cooper Consumer Health